Compounds > arabinofuranosylcytosine triphosphate

arabinofuranosylcytosine triphosphate and Benign Neoplasms

arabinofuranosylcytosine triphosphate has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Milano, G1
Milano, GA; Peters, GJ; Schornagel, JH1

Reviews

1 review(s) available for arabinofuranosylcytosine triphosphate and Benign Neoplasms

ArticleYear
Clinical pharmacokinetics of anti-metabolites.
    Cancer surveys, 1993, Volume: 17

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cytarabine; Fluorouracil; Humans; Mercaptopurine; Methotrexate; Neoplasms

1993

Other Studies

1 other study(ies) available for arabinofuranosylcytosine triphosphate and Benign Neoplasms

ArticleYear
[Increase of dose intensity by pharmacomodulation. General concepts and therapeutic applications].
    Bulletin du cancer, 1995, Volume: 82 Suppl 1

    Topics: Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Fluorouracil; Leucovorin; Neoplasms

1995